Monthly Archives: November 2016

North America Is Expected To Dominate The Global Healthcare Analytics/ Medical Analytics Market

Based on delivery model, the market is segmented into on-demand and on-premise model. The on-demand segment is expected to grow at highest CAGR due to rise in demand for self-driven analytics, lack of upfront capital investments for hardware, extreme capacity flexibility

Seattle, United States – November 30, 2016 /MarketersMedia/ —

The report “Healthcare Analytics/ Medical Analytics Market by Application (Clinical, RCM, Claim, Fraud, Supply Chain, HR, PHM), Type (Prescriptive), Component (Service, Software), Delivery (On-premise, Cloud), End User (Hospital, Payer, ACO, TPA) – Forecasts to 2021″, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

The global healthcare analytics market is expected to reach USD 24.55 Billion by 2021 from USD 7.39 Billion in 2016, at a CAGR of 27.1% during the forecast period.

The growth of this market is mainly driven by factors such as increasing government initiatives to enhance EHR adoption, rising pressure to curb healthcare spending and need for improved patient outcomes, availability of big data in healthcare, rise in venture capital investments, and technological advancements. Moreover, use of analytics in precision and personalized medicine, increasing focus on value-based medicine and cloud-based analytics, increasing number of patient registries, and emergence of social media and its impact on the healthcare industry provide significant growth opportunities in the market. However, lack of skilled professionals, high cost of analytics solutions, and operational gaps between payers and providers may hinder the growth of this market during the forecast period.

The report segments the healthcare analytics market based on type, application, component, delivery model, end user, and region. Based on type, the healthcare analytics market is segmented into descriptive, predictive and prescriptive analytics. The descriptive analytics segment is expected to account for the largest share of the healthcare analytics market in 2016. The significant usage of descriptive analytics by healthcare providers to gain a better understanding of the past trends and event occurring in real-time, is expected to drive the growth of the descriptive analytics market during the forecast period. Based on delivery model, the healthcare analytics market is segmented into on-demand and on-premise models. The on-demand model segment is expected to grow at the highest CAGR during the forecast period due to its advantages such as growing demand for self-driven analytics, lack of upfront capital investments for hardware, extreme capacity flexibility, and the pay-as-you-go pricing of this model.

Based on region, the healthcare analytics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to dominate the market, followed by Europe. North America is poised to be the fastest-growing region during the forecast period. Factors such as growing federal healthcare mandates to curb rising healthcare costs and provide quality care; increasing regulatory requirements; growing EHRs adoption; and rising government initiatives to focus on personalized medicine, population health management, and value-based reimbursements will drive market growth in North America.

The healthcare analytics market is a highly fragmented market, with several big and emerging players. Key market players include IBM Corporation (U.S.), Optum, Inc. (U.S.), Cerner Corporation (U.S.), SAS Institute, Inc. (U.S.), Allscripts Health Solutions (U.S.), McKesson Corporation (U.S.), MedeAnalytics, Inc. (U.S.), Inovalon (U.S.), Oracle Corporation (U.S.), Verisk Analytics (U.S.), and Health Catalyst (U.S.).

For more information, please visit http://www.marketsandmarkets.com/pdfdownload.asp?id=905

Contact Info:
Name: Rohan
Organization: MarketsandMarkets
Address: 701 Pike Street Suite 2175, Seattle, WA 98101, United States
Phone: 1-888-600-6441

Source: http://marketersmedia.com/north-america-is-expected-to-dominate-the-global-healthcare-analytics-medical-analytics-market/150506

Release ID: 150506

J.D. Byrider and its 169 Buy Here Pay Here Dealerships, Announces the Launch of an Early Bird Tax Refund Event

People with Credit Challenges can get a Reliable Car Today Using their Pay Stub to get an Advance on their Tax Refund

CARMEL, IN / ACCESSWIRE / November 30, 2016 / J.D. Byrider, headquartered in Carmel, Indiana, is pleased to announce the Early Bird Tax Refund Event, which can help those with poor credit or no credit get a reliable car today.

To learn more about J.D. Byrider and how they can help many people with bad credit to get a safe and reliable car, please visit http://www.jdbyrider.com/Why-JD-Byrider/buy-here-pay-here-car-dealer.

People who wish to take part in the Early Bird Tax Refund Event should bring in a paystub to the dealership.

“The average J.D. Byrider customer with one child received a refund of over $5,000 and over 10 percent of them received over $8,000,” noted a company spokesperson.

Since J.D. Byrider first opened, they have earned a well-deserved reputation for helping people with less-than-perfect credit get the safe and dependable car that they need and deserve. In addition to an easy credit approval process and affordable payments, J.D. Byrider also offers a wide variety of used cars for sale that include a limited warranty or a service contract and low-cost service and repairs.

To listen to customers who have had outstanding experiences with J.D. Byrider, please check out the video at https://www.youtube.com/watch?v=MWjVvzY-5c4.

“J.D. Byrider’s friendly loan experts base your approval on your current financial situation and ability to make easy payments, not past mistakes,” noted the spokesperson.

About J.D. Byrider:

J.D. Byrider is different than many buy here pay here dealerships. They offer far more than just transportation – their customers get a safe and reliable car with simple on-site financing, affordable payments and low-cost car care. They also get the security of knowing that J.D. Byrider has helped over 1.2 million customers over the more than 25 years they’ve been in business. For more information, please visit http://www.jdbyrider.com/.

J.D. Byrider
12802 Hamilton Crossing Blvd.
Carmel, IN 46032

Contact:

Corey Wenger
contact@JDByrider.com
317-249-3000

SOURCE: J.D. Byrider

ReleaseID: 450028

Weston SEO and PPC Digital Marketing Agency Announces New Strategic Alliance

Digital marketing agency Hooked On Social serving Weston, Miami, WPB announced a new alliance to provide SEO, PPC and Content Marketing with divorce and family law firm Pazos Family Law. They’re helping expand Pazos Family Law’s client base in South Florida.

Weston, United States – November 30, 2016 /PressCable/ —

Hooked On Social, an elite digital marketing agency specialized in SEO, Pay-Per-Click, and Social Media servicing Weston, Miami and West Palm Beach just announced a new strategic alliance with Pazos Family Law, a divorce firm servicing South Florida.

More information is available at http://www.hookedon.social.

Hooked On Social’s new strategic alliance with Pazos Family Law helps this renowned law firm increase their audience, reputation and client base by taking their internet marketing to a leadership level not available to most law firms.

Pazos Family Law specializes in divorce and family law and their policy is to take a collaborative approach helping clients get through the difficult transition of divorce so they can move on to bigger and better things. They pride themselves in being transparent about a client’s options so they know what to expect and never feel alone or confused in what can often be a very confusing process.

Pazos Family Law is excited to form an alliance with a digital marketing agency who will help them with elite digital marketing services to share their core values to a wider audience and accomplish their growth objectives.

Mario Pazos, COO at Pazos Family Law says “PFL’s vision is to become the premier, exemplary family law office in South Florida, positively impacting our community and legal landscape. In order for us to achieve this goal we are pleased to partner with Hooked On Social to implement an online marketing strategy that will allow us reach to our target customers and provide them with high quality services.” http://www.pazosfamilylaw.com.

Hooked On Social digital marketing efforts to support this strategic alliance focuses on SEO management, content marketing, pay-per-click advertising and social media marketing, including its newly introduced service dubbed Facebook Live for business.

The agency specializes in producing leads and sales for businesses using their three step formula that drives online traffic, keeps audiences engaged and converts prospects into paying customers with the highest return on investment.

For more information on the new alliance and the services provided by Hooked On Social interested parties can go to the website listed above.

For more information, please visit http://www.hookedon.social

Contact Info:
Name: France Jubinville
Organization: Hooked On Social
Address: 307 Lake Crest Ct. Weston FL 33326
Phone: +1 954 530 9238

Release ID: 149087

US$ 1.4 Bn PCB Design Software Market Poised to Witness Steady Growth: Report

The global PCB design software market is projected to grow at nearly 13% CAGR through 2026. Consumer electronics sector will continue to be account for bulk of the demand.

Valley Cottage, United States – November 30, 2016 /MarketersMedia/ —

Future Market Insights delivers key insights on the global PCB design software market in a new report titled “PCB Design Software Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”. The global PCB design software market is anticipated to grow from US$ 1,409.3 Mn in 2016 to US$ 4,755.1 Mn by 2026, registering a CAGR of 12.9% in terms of revenue during the forecast period (2016-2026). In this report, the global PCB design software market is tracked in terms of value, and is calibrated to obtain the market revenue estimates.

PCB design software is used by engineers for designing the printed circuit board on a device, using various features that aim to address issues an engineer faces such as those related to signal and power integrity, while designing a PCB and ease the overall designing process. PCB design software is integrated with other related software such as PLM, which helps engineers to better understand designs and layouts of PCBs.

Request Sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-854

Need to ease the design process and growing complexity of circuits are factors anticipated to drive growth of the global PCB design software market over the forecast period. Growth in the end-user industries are further expected to push the demand for global PCB design software market during the forecast period. However, rapid introduction of new technologies and pirated software are major challenges expected to be faced by market players in the global PCB design software market during the forecast period.

Segmentation highlights

The overall global PCB design software market is segmented on the basis of type, end-user, and region.

The section – market analysis, by type, comprehensively analyses the market on the basis of type and presents an in-depth analysis of the market size in terms of value for 2016-2026. In 2015, the mainstream software segment dominated the global PCB design software market, followed by the high-end software segment. Moreover, mainstream software segment is anticipated to expand at the fastest CAGR of 13.7% over the forecast period in the global PCB design software market in terms of revenue, followed by high-end software segment.

Preview on PCB Design Software Market Segmentation by Type – High-End Software, Mainstream Software and Low-End Software; by End User – Computing Industry, Consumer Electronics Industry, Communications Industry, Medical Industry, Defence Industry and Automotive Industry: http://www.futuremarketinsights.com/reports/pcb-design-software-market

The section – market analysis by end-user, analyses the global PCB design software market on the basis of types of end-users in the global PCB design software market and the data is provided in terms of value for 2016-2026. The defence industry segment is expected to expand at the highest CAGR of 14.4% in terms of value during the forecast period.

In terms of market share, consumer electronics industry segment and defence industry segment together accounted for around half of the revenue share of the overall market in 2015 and consumer electronics industry is expected to dominate the global PCB design software market throughout the forecast years.

Regional projections

The section – market analysis by region, includes an in-depth country level analysis of all global regions namely, North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa, provides market data in terms of value for 2016-2026. In 2015, market in North America region dominated the overall global PCB design software market, followed by the market in Asia Pacific excluding Japan region. The PCB design software market in Asia Pacific excluding Japan region is forecast to expand at the highest CAGR over the forecast period.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-854

Vendor insights

Key players reported in this study on the global PCB design software market include Cadence Design Systems, Inc., Mentor Graphics Corporation, Zuken Inc., Altium LLC, ANSYS, Inc., Synopsys, Inc., WestDev Ltd. and Autodesk Inc.

For more information, please visit http://www.futuremarketinsights.com/reports/pcb-design-software-market

Contact Info:
Name: Abhishek Budholiya
Organization: Future Market Insights
Address: 616 Corporate Way, Suite 2-9018,, Valley Cottage, NY 10989,, United States
Phone: +13479183531

Source: http://marketersmedia.com/us-1-4-bn-pcb-design-software-market-poised-to-witness-steady-growth-report/150809

Release ID: 150809

Bird Golf Announces New Partnership and New Tucson Golf School at the Hilton Tucson El Conquistador Golf & Tennis Resort

Bird Golf Academy is pleased to announce a new partnership and a new Tucson golf school at the Hilton Tucson El Conquistador Golf & Tennis Resort

LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / Bird Golf Academy, a premier provider of personalized golf instruction to golfers of all ages and abilities, is pleased to announce a new partnership and a new Tucson golf school at the Hilton Tucson El Conquistador Golf & Tennis Resort.

As a spokesperson for The Bird Golf Academy noted, El Conquistador Golf & Tennis Resort has earned a well-deserved reputation for being one of the most scenic golf courses in the country, blending natural fauna seamlessly throughout the course. Thanks to the new partnership with Bird Golf Academy, El Conquistador Golf & Tennis Resort will be the location of one of the best golf schools in Arizona.

“We are extremely pleased to be partnering with Bird Golf at El Conquistador Golf & Tennis Resort,” said El Conquistador Golf & Tennis Club General Manager, Tom Meade. “Troon Golf has had great success at other properties working with the Professional team at Bird Golf. I look forward to the opportunity to grow the game with Bird Golf and El Conquistador Golf & Tennis Resort.”

Bird Golf student packages will include a private appointed Junior Suite, renovated in 2016, with rooms overlooking the surrounding Santa Catalina Mountains. The package will also include unlimited practice and play at the El Conquistador course, a player evaluation, work on the Mental Game, lunch with a PGA/LPGA professional every day, and 18, 24 or 30 hours of instruction with a Bird Golf Academy professional. Bird Golf students will also have access to private El Conquistador practice facilities, while still being able to enjoy the superb layout of the two courses.

When done for the day, Junior Suites feature luxury bedding and private balcony views of the picturesque mountain ranges surrounding El Conquistador Golf & Tennis Resort.

El Conquistador blends the stunning natural beauty of the area with a premier parkland setting. The recently renovated par-71 course designed by Greg Nash is framed with mesquite and Palo Verde trees indigenous to the region, weaving vibrant native flora and incredible views with top-notch course quality. The par-72 Canada course features breathtaking mountain views and subtle elevation changes complimenting the amazing vistas of the surrounding desert wildlife.

About Bird Golf Academy:

Bird Golf Academy is a leader in personalized golf instruction, providing one-to-one and two-to-one golf classes to golfers of all ages and skill levels. With 21 locations throughout the U.S., the Bird Golf Academy connects golf students with acclaimed PGA and LPGA instructors in 10 states. The academy’s teaching staff includes an LPGA National Teacher of the Year, 2 US Open Champions, PGA Master professionals and multiple award-winning PGA professionals. It is the format and quality of golf instruction that separates Bird Golf Academy from other golf schools.

For more information, please visit http://www.birdgolf.com/

Contact:

Skyler Malley
skyler@birdgolf.com
3039096698

Contact:

Tommy Paul
admin@rocketfactor.com
(949) 555-2861

SOURCE: Bird Golf Academy

ReleaseID: 450025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Centene Corp. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 13, 2017 – CNC

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Centene Corp. (“Centene”) (NYSE: CNC) between April 26, 2016 and September 6, 2016.

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. If you purchased or otherwise acquired Centene securities between April 26, 2016 and September 6, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/centene-corp or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that during the Class Period, Centene made materially false and misleading statements concerning the acquisition of Health Net, Inc. and failed to disclose: (1) that certain Health Net insurance programs were significantly underperforming, which led to the need to increase reserves to offset losses caused by these programs; (2) that Centene overstated the financial prospects of Health Net; and (3) that as a result of the above, the Company’s statements concerning its business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times.

If you suffered a loss in Centene, you have until January 13, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 450042

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alere Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 13, 2017 – ALR

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Alere Inc. (“Alere”) (NYSE: ALR) between February 29, 2012 and November 4, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. To get more information go to: http://www.zlk.com/pslra/alere or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that Alere made false and misleading statements and/or failed to disclose: (1) that the Company’s wholly-owned subsidiary, Arriva Medical, LLC (“Arriva”), was submitting claims to Medicare for deceased patients; (2) that this conduct subjected Arriva to revocation of its Medicare enrollment; and (3) that as a result of the above, Alere’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times.

On November 4, 2016, Alere disclosed that the Centers for Medicare and Medicaid Services alleged that Arriva submitted claims for 211 deceased patients over a five-year period, and thus revoked Arriva’s Medicare enrollment. Following this new, shares of Alere fell from a close of $42.23 on November 3, 2016, to a close of $36.10 per share.

If you suffered a loss in Alere, you have until January 13, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 450041

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Arrowhead Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 – ARWR

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Arrowhead Pharmaceuticals, Inc. (“Arrowhead”) (NASDAQ: ARWR) between May 11, 2015 and November 8, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Central District of California. To get more information go to: http://www.zlk.com/pslra/arrowhead-pharmaceuticals or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that during the Class Period, Arrowhead made false and misleading statements and/or failed to disclose that: (1) its drug candidate ARC-520 was fatal at certain doses; (2) the U.S. Food & Drug Administration was unlikely to approve ARC-520 as a hepatitis B treatment; (3) the Company overstated the approval prospects and commercial viability of ARC-520; and (4) as a result of the above, Arrowhead’s public statements were materially false and misleading at all relevant times.

On November 8, 2016, after the close of the market, Arrowhead Pharmaceuticals announced that the United States Food & Drug Administration had decided to place a clinical hold on the Company’s Heparc-2004 clinical study of ARC-520. According to the company, the hold stems from deaths at the highest dose of an ongoing non-human primate toxicology study.

If you suffered a loss in Arrowhead, you have until January 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 450039

EXPANDED CLASS PERIOD: Levi & Korsinsky, LLP Notifies Shareholders of Cempra, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 3, 2017 – CEMP

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Cempra, Inc. (NASDAQ: CEMP) between October 22, 2015 and November 1, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Middle District of North Carolina. To get more information go to: http://www.zlk.com/pslra/cempra-inc or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that during the Class Period, Cempra made false and/or misleading statements and/or failed to disclose that: (i) Cempra’s lead product candidate solithromycin posed significant safety risks for hepatotoxicity; and (ii) as a result of the foregoing, Cempra’s public statements were materially false and misleading at all relevant times.

On November 2, 2016, the U.S. Food and Drug Administration posted a preliminary review of solithromycin, highlighting a significant safety signal for hepatotoxicity. Upon this news, shares of Cempra fell over 60% during intraday trading.

If you suffered a loss in Cempra, you have until January 3, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 450040

SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ProNAi Therapeutics, Inc. (DNAI) & Lead Plaintiff Deadline: January 9, 2017

NEW YORK, NY / ACCESSWIRE / November 30, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ProNAi Therapeutics, Inc. (“ProNAi” or the “Company”) (NASDAQ: DNAI) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired ProNAi securities between July 15, 2015 and June 6, 2016, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/dnai.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements about the potential and effectiveness of its drug product candidate PNT2258 in its public filings, causing ProNAi’s stock to be falsely inflated throughout the Class Period.

On June 6, 2016, ProNAi released its interim results from the Wolverine Phase 2 trial of PNT2258 for the treatment of relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL). Nick Glover, President and CEO said, “Although [PNT2258] observed modest efficacy …in [the] interim analysis of Wolverine,” the Company has “decided to suspend the development of PNT2258” because the results were not “robust enough to justify continued development of the drug in DLBCL.” Following this news, ProNAi stock dropped from a previous market close on June 3 of $6.38 per share to close at just $2.07 per share on June 6, 2016.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/dnai or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in ProNAi you have until January 9, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 449281